Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.3, 2013-03, pp. : 333-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA minor groove alkylating agents

By Denny W.A.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 4, 2000-04 ,pp. : 459-474

Informa Healthcare

Access to resources Recommend Favorite

DNA Minor Groove Alkylating Agents

Current Medicinal Chemistry, Vol. 8, Iss. 5, 2000-05 ,pp. : 533-544

Bentham Science Publishers

Access to resources Recommend Favorite

Distamycin A as Stem of DNA Minor Groove Alkylating Agents

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 2, 2004-01 ,pp. : 231-239

Bentham Science Publishers

Access to resources Recommend Favorite

Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution

By Bouazzaoui Abdellatif Dickhöfer Sabine Kreuz Marina Huber Elisabeth Holler Ernst Wolff Daniel

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 158-164

Informa Healthcare

Access to resources Recommend Favorite

DNA minor groove alkylating agents structurally related to distamycin A

By Baraldi P.G. Spalluto G. Cacciari B. Romagnoli R.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 891-904

Informa Healthcare

Access to resources Recommend Favorite